Parameters

SSFA2 phenotype—n (%)

SFA2 phenotype—n (%)

Inclusion

M12

Inclusion

M12

Sleeping and eating disorders

21 (63.6%)

4 (13.8%)

4 (66.7%)

1 (16.7%)

Joint and abdominal pains

19 (57.6%)

13 (44.8%)

3 (50.0%)

2 (33.3%)

Hospitalization/transfusion

26 (78.8%)

1 (3.4%)

4 (66.7%)

-

Jaundice

25 (75.8%)

21 (72.4%)

4 (66.7%)

3 (50.0%)

Liver damage

4 (12.1%)

-

1 (16.7%)

-

Kidney damaged

1 (3.0%)

1 (3.4%)

1 (16.7%)

-

Spleen damaged

18 (54.5%)

2 (6.9%)

-

-

Deaths

4 (12.1%)

-

HbF levels below 10%

19 (57.6%)

6 (20.7%)

3 (50.0%)

-

HbF levels (average ± SD %)

9.0 ± 5.6

13.9 ± 7.2

17.6 ± 6.6

18.4 ± 6.8

Between 6 and 12 months age

4 (12.1%)

-

Between 13 and 24 months age

7 (21.2%)

1 (16.7%)

More than 24 months age

22 (66.7%)

5 (66.7%)

Hb (G/dL)

6.9 ± 1.9

8.1 ± 1.6

6.7 ± 3.3

9.3 ± 1.0

Minimum-Maximum age

5.1 - 8.5

5.4 - 13.2

6.6 - 8.4

7.8 - 10.0

Hypochromia

17 (51.5%)

13 (44.8%)

3 (50.0%)

3 (50.0%)

Microcytosis

9 (27.2%)

6 (20.7%)

2 (33.3%)

4 (66.7%)

White blood cells—WBC count (×103)

12.8 ± 4.7

9.8 ± 3.1

12.5 ± 3.1

9.5 ± 2.1

Minimum-Maximum WBC count

8.2 - 30.0

4.1 - 15.1

11.8 - 16.2

7.6 - 12.4

Platelets count (×105)

371 ± 113

315 ± 109

400 ± 117

273 ± 95

Minimum-Maximum Platelet count

252 - 679

145 - 609

381 - 438

151 - 354

Total

33

30

6

5